Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian share markets open weak
Thu, 31 Jul 09:30 am

Barring Singapore (up 0.9%) and Japan (up 0.4%), major Asian stock markets have opened the day on a weak note with stock markets in Taiwan (down 1.3%) and South Korea (down 0.3%) leading the losses. The Indian share markets have opened the day on a negative note. The sectoral indices have opened on a mixed note with IT stocks leading the losses. However, metal and realty stocks are trading firm.

The Sensex today is marginally down by around 25 points (0.1%), while the NSE-Nifty is down by about 15 points (0.2%). However, mid and small cap stocks are trading in the green with the BSE Mid Cap and BSE Small Cap indices up by around 0.4% each. The rupee is currently trading at Rs 60.08 to the US dollar.

Textile stocks have opened the day on a mixed note with Eastern Silk Industries, Bombay Dyeing and Arvind Ltd leading the losses. However, Raymond and Vardhman Textiles are trading firm. As per a leading financial daily, one of the leading integrated textile and branded apparel manufacturer Arvind Ltd is set to demerge its real estate business and transfer it to the company's wholly-owned subsidiary Arvind Infrastructure Ltd (AIL). The company also has plans to list AIL on the stock exchanges. AIL will issue one share of Rs 10 each for every 10 shares of Rs 10 held by shareholders of Arvind Ltd. It must be noted that AIL manages 11 real-estate projects in Ahmedabad and Bangalore with 5.3 million square feet over 360 acres of land.

Indian Pharma stocks have opened the day on a mixed note with Torrent Pharma and Aurobindo Pharma leading the gains. However, Cadila Healthcare and Divi's Laboratories are trading in the red. As per a leading financial daily, Mumbai-based drug maker Lupin Ltd has said that it will contest the decision of the European Union to impose 40 million euro penalty on it. It must be noted that the anti-trust wing of the European Commission recently slapped a fine on Lupin for attempting to obstruct the entry of low-cost generic version of cardiovascular medicine Perindropril in the European Union. However, Lupin is confident of its position and is planning to appeal against the decision in the next few days. A couple of other Indian players who were also pulled up by the commission include Unichem Laboratories and Matrix Laboratories.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian share markets open weak". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.